Sandoz International GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sandoz International GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5150
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sandoz International GmbH (Sandoz), a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products. The company provides biosimilars, generic antibiotics, dermatology and transplantation medicines. Its biosimilars comprise Omnitrope, Binocrit and Zarzio products. Sandoz offers products for oncology, central nervous system (CNS), respiratory, pain and ophthalmology. It offers products in the form of creams and gels, tablets, orodispersible films, transdermal patches, implants and inhalers. The company sells its products through a network of distributors in Germany and abroad. It has presence in Austria, Italy, Russia, the UK, France, Canada, the US, and Belgium among others. Sandoz is headquartered in Holzkirchen, Germany.

Sandoz International GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sandoz International GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sandoz International GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Sandoz Acquires Rights of Biosimilar Infliximab from Pfizer 11
Partnerships 12
Sandoz International Enters into Agreement with Biocon 12
MedinCell Enters into Agreement with Sandoz International 13
Sandoz Enters Into Co-promotion Agreement With Nipro Pharma For Somatropin BS S.C. Injection 5mg/10mg [Sandoz] 14
Licensing Agreements 15
Sandoz International Enters into Licensing Agreement with DSM Sinochem Pharma 15
Kyowa Hakko Kirin Enters into Licensing Agreement with Sandoz 16
Sandoz International GmbH – Key Competitors 17
Sandoz International GmbH – Key Employees 18
Sandoz International GmbH – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Apr 11, 2017: Major Novartis investment in Slovenia reinforces commitment to largest Sandoz product and business 20
Feb 08, 2017: Sandoz confirms strategic commitment to drive access to medicines in Japan, with plan to double business by 2022 21
Legal and Regulatory 22
Jun 13, 2017: US Supreme Court rules in favor of Sandoz in biosimilars case, enabling earlier access to potentially life-saving medicines 22
Jun 12, 2017: US Supreme Court clears way to early access to biosimilars 23
Product Approvals 24
Jan 27, 2017: Withdrawal of the marketing authorisation application for Zioxtenzo (pegfilgrastim) 24
Other Significant Developments 25
Aug 29, 2017: Sandoz Invests in Major Expansion of Global Headquarters in Holzkirchen, Germany 25
Jul 25, 2017: Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries 26
Mar 20, 2017: Sandoz digital “Scientific Standalone” event will help drive access to medical information in field of cardiovascular therapies 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Sandoz International GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sandoz International GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sandoz International GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Sandoz International GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sandoz Acquires Rights of Biosimilar Infliximab from Pfizer 11
Sandoz International Enters into Agreement with Biocon 12
MedinCell Enters into Agreement with Sandoz International 13
Sandoz Enters Into Co-promotion Agreement With Nipro Pharma For Somatropin BS S.C. Injection 5mg/10mg [Sandoz] 14
Sandoz International Enters into Licensing Agreement with DSM Sinochem Pharma 15
Kyowa Hakko Kirin Enters into Licensing Agreement with Sandoz 16
Sandoz International GmbH, Key Competitors 17
Sandoz International GmbH, Key Employees 18
Sandoz International GmbH, Subsidiaries 19

List of Figures
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sandoz International GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sandoz International GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CBR Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary CBR Systems Inc (CBR), a subsidiary of AMAG Pharmaceuticals Inc is a stem cell company that offers newborn stem cells. The company designs and implements technologies and processes for cord blood banking. It offers cord blood banking service that stores newborn's umbilical cord blood; and co …
  • UroGen Pharma Ltd (URGN)-製薬・医療分野:企業M&A・提携分析
    Summary UroGen Pharma Ltd (UroGen Pharma), formerly TheraCoat Ltd is a biopharmaceutical company that develops uro-oncology drugs and urological pathologies. The company’s pipeline products comprise drug candidates for various forms of non-muscle invasive urothelial cancer, including low grade bladd …
  • Dynasil Corporation of America (DYSL)-医療機器分野:企業M&A・提携分析
    Summary Dynasil Corporation of America (Dynasil) is an electronic equipment company that develops and manufactures optics and photonics products. The company also offers optical detection and analysis technology and components. It provides products such as beamsplitters, diffraction gratings, infrar …
  • The Scripps Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institut …
  • PotlatchDeltic Corporation (PCH):企業の財務・戦略的SWOT分析
    PotlatchDeltic Corporation (PCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Staatsolie Maatschappij Suriname NV:企業の戦略的SWOT分析
    Staatsolie Maatschappij Suriname NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • MSL Solutions Limited (MPW):企業の財務・戦略的SWOT分析
    MSL Solutions Limited (MPW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Bta Bank Jsc
    Bta Bank Jsc - Strategy, SWOT and Corporate Finance Report Summary Bta Bank Jsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • United Cooperative Services, Inc.:企業の戦略的SWOT分析
    United Cooperative Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Electricity Generating Authority of Thailand:企業の戦略・SWOT・財務情報
    Electricity Generating Authority of Thailand - Strategy, SWOT and Corporate Finance Report Summary Electricity Generating Authority of Thailand - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Ishihara Sangyo Kaisha Ltd (4028):企業の財務・戦略的SWOT分析
    Ishihara Sangyo Kaisha Ltd (4028) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cleco Corporate Holdings, LLC:企業の戦略・SWOT・財務情報
    Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report Summary Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Care UK Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Care UK Ltd (Care UK) is a healthcare service provider that offers clinical and social care services. The company’s healthcare services include treatment centres, General Practitioner(GP) practices, NHS walk-in centres, GP out-of-hours, prison health services, clinical assessment, diagnostic …
  • bebe stores, inc.:戦略・SWOT・企業財務分析
    bebe stores, inc. - Strategy, SWOT and Corporate Finance Report Summary bebe stores, inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Enercon GmbH:企業の戦略的SWOT分析
    Enercon GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Eloxx Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Eloxx Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eloxx Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • OSRAM Opto Semiconductors GmbH:企業の戦略的SWOT分析
    OSRAM Opto Semiconductors GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Owensboro Municipal Utilities:企業の発電所・SWOT分析2018
    Owensboro Municipal Utilities - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Prothena Corp Plc (PRTA)-医療機器分野:企業M&A・提携分析
    Summary Prothena Corp Plc (Prothena) is a biotechnology company that discovers, develops and markets novel antibodies that are indicated for the treatment of diseases associated with amyloid or cell adhesion. The company develops monoclonal antibodies directed specifically at disease-causing protein …
  • Biocept Inc (BIOC)-製薬・医療分野:企業M&A・提携分析
    Summary Biocept Inc (Biocept) is a developer of diagnostic solutions. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers related instrumentation, OncoCEE technology, and analytica …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆